Introduction
This document provides information on the treatment of Lyme disease (Borreliosis) using Bionic 880 Photon Therapy, developed by Dr. med. Ingo D. E. Woitzel. It emphasizes a non-antibiotic approach to managing the disease.

Understanding Lyme Disease
Lyme disease can mimic various other conditions such as multiple sclerosis, rheumatism, fibromyalgia, and more. It can affect any organ and should be considered in differential diagnoses.

Diagnostics
Diagnosis of Borreliosis involves laboratory tests like Elisa and Westernblot, which detect specific antibodies. However, these tests do not indicate the activity of the infection. The German Lyme-Disease-Association recommends the LTT-Test for active Borreliosis detection. The T-Cell-Spot-Test is not yet recommended due to insufficient validation. NK cell activity measurement and Borrelia DNA gene evidence are additional diagnostic methods.

Dr. Woitzel's Perspective
Dr. Woitzel advocates for energetic analysis methods over traditional lab tests, citing their reliability based on his experience. He emphasizes the importance of understanding photon effects in cells and quantum physics principles.

Photon Therapy Treatment
The Bionic 880 device, combined with specific Borrelia nosodes, is used for treating Lyme disease without antibiotics. Typically, 5-7 treatments are sufficient to alleviate symptoms. The device is a certified medical tool, and its principles can be applied to other diseases.

Device Information
The Bionic 880 is manufactured by H. Buschkühl GmbH, which received the 'Industriepreis 2008' for this innovative treatment method. Detailed therapy instructions are provided with the device purchase.

Contact Information
H. Buschkühl GmbH, Georg-Büchner-Straße 62, D-40699 Erkrath, Germany. Phone: +49 (0)211 253186, Fax: +49 (0)211 208022, Website: www.biophoton.de, Email: [email protected]